Skip to main content
. 2020 Dec 17;5(51):32861–32867. doi: 10.1021/acsomega.0c01541

Figure 5.

Figure 5

(A) Viability of A549/Dox cells treated with different formulations at different drug concentrations for 48 h. (B) Volume changes of MCTS after different treatments. Data were expressed as the mean standard deviation of three samples.